Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiurong Ke

Showing results (11-20 of 41) with videos related to

Pageof 5
Sort By:
International Journal of Bioprinting|February 27, 2023
Application of 3D-bioprinted nanocellulose and cellulose derivative-based bio-inks in bone and cartilage tissue engineeringLan Lin, Songli Jiang, Jun Yang, et al.
Oncoimmunology|December 10, 2020
Bispecific antibody approach for EGFR-directed blockade of the CD47-SIRPα "don't eat me" immune checkpoint promotes neutrophil-mediated trogoptosis and enhances antigen cross-presentationMark A J M Hendriks, Emily M Ploeg, Iris Koopmans, et al.
Bioactive Materials|November 19, 2020
Bone tissue regeneration: The role of finely tuned pore architecture of bioactive scaffolds before clinical translationRonghuan Wu, Yifan Li, Miaoda Shen, et al.
Biomedical Materials (Bristol, England)|June 8, 2017
Systematic evaluation of the osteogenic capacity of low-melting bioactive glass-reinforced 45S5 Bioglass porous scaffolds in rabbit femoral defectsLei Zhang, Xiurong Ke, Lingzhi Lin, et al.
ACS Applied Materials & Interfaces|July 18, 2017
Enhancing the Osteogenic Capability of Core-Shell Bilayered Bioceramic Microspheres with Adjustable BiodegradationXiurong Ke, Chen Zhuang, Xianyan Yang, et al.
International Journal of Molecular Sciences|May 30, 2015
Dysregulation of PAK1 Is Associated with DNA Damage and Is of Prognostic Importance in Primary Esophageal Small Cell CarcinomaJinfeng Gan, Yuling Zhang, Xiurong Ke, et al.
Oncoimmunology|December 3, 2021
Cancer cells under immune attack acquire CD47-mediated adaptive immune resistance independent of the myeloid CD47-SIRPα axisMark A J M Hendriks, Isabel Britsch, Xiurong Ke, et al.
Oncoimmunology|May 14, 2023
Novel Fab-peptide-HLA-I fusion proteins for redirecting pre-existing anti-CMV T cell immunity to selective eliminate carcinoma cellsIsabel Britsch, Anne P van Wijngaarden, Xiurong Ke, et al.
Cancers|July 29, 2023
A Novel Bispecific Antibody for EpCAM-Directed Inhibition of the CD73/Adenosine Immune Checkpoint in Ovarian CancerEmily Maria Ploeg, Isabel Britsch, Anne Paulien van Wijngaarden, et al.
Journal of Immunology Research|January 18, 2021
Tumor-Infiltrating Immune Cells and PD-L1 as Prognostic Biomarkers in Primary Esophageal Small Cell CarcinomaXiao Wu, Xiurong Ke, Yangpeng Ni, et al.
Pageof 5

Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
International Journal of Bioprinting|February 27, 2023
Application of 3D-bioprinted nanocellulose and cellulose derivative-based bio-inks in bone and cartilage tissue engineeringLan Lin, Songli Jiang, Jun Yang, et al.
Oncoimmunology|December 10, 2020
Bispecific antibody approach for EGFR-directed blockade of the CD47-SIRPα "don't eat me" immune checkpoint promotes neutrophil-mediated trogoptosis and enhances antigen cross-presentationMark A J M Hendriks, Emily M Ploeg, Iris Koopmans, et al.
Bioactive Materials|November 19, 2020
Bone tissue regeneration: The role of finely tuned pore architecture of bioactive scaffolds before clinical translationRonghuan Wu, Yifan Li, Miaoda Shen, et al.
Biomedical Materials (Bristol, England)|June 8, 2017
Systematic evaluation of the osteogenic capacity of low-melting bioactive glass-reinforced 45S5 Bioglass porous scaffolds in rabbit femoral defectsLei Zhang, Xiurong Ke, Lingzhi Lin, et al.
ACS Applied Materials & Interfaces|July 18, 2017
Enhancing the Osteogenic Capability of Core-Shell Bilayered Bioceramic Microspheres with Adjustable BiodegradationXiurong Ke, Chen Zhuang, Xianyan Yang, et al.
International Journal of Molecular Sciences|May 30, 2015
Dysregulation of PAK1 Is Associated with DNA Damage and Is of Prognostic Importance in Primary Esophageal Small Cell CarcinomaJinfeng Gan, Yuling Zhang, Xiurong Ke, et al.
Oncoimmunology|December 3, 2021
Cancer cells under immune attack acquire CD47-mediated adaptive immune resistance independent of the myeloid CD47-SIRPα axisMark A J M Hendriks, Isabel Britsch, Xiurong Ke, et al.
Oncoimmunology|May 14, 2023
Novel Fab-peptide-HLA-I fusion proteins for redirecting pre-existing anti-CMV T cell immunity to selective eliminate carcinoma cellsIsabel Britsch, Anne P van Wijngaarden, Xiurong Ke, et al.
Cancers|July 29, 2023
A Novel Bispecific Antibody for EpCAM-Directed Inhibition of the CD73/Adenosine Immune Checkpoint in Ovarian CancerEmily Maria Ploeg, Isabel Britsch, Anne Paulien van Wijngaarden, et al.
Journal of Immunology Research|January 18, 2021
Tumor-Infiltrating Immune Cells and PD-L1 as Prognostic Biomarkers in Primary Esophageal Small Cell CarcinomaXiao Wu, Xiurong Ke, Yangpeng Ni, et al.
Pageof 5